Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Immtech to Start CRO with Beijing Capital Medical University

publication date: Jun 20, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Immtech Pharmaceuticals signed a Memorandum of Understanding with Beijing Capital Medical University (BCMU) to establish a joint venture that provides contract research services (CRS) in China. The joint venture will provide drug discovery services. Immtech is a newcomer to the CRS/CRO space. Its traditional focus has been on drug development. More details...

Stock Symbol: (AMEX: IMM)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners